Coronavirus Infection
198
5
6
113
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
26 trials with published results (13%)
Research Maturity
113 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.6%
27 terminated out of 198 trials
80.7%
-5.8% vs benchmark
14%
27 trials in Phase 3/4
23%
26 of 113 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 113 completed trials
Clinical Trials (198)
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
Hydroxychloroquine in Outpatient Adults With COVID-19
Study of the Pathogenesis of Olfactory Disorders in COVID-19
Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)
Post COVID-19 Biorepository
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response
Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19)
COVID-19 Health Professional Impact Study
Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
Relative Bioavailability Study of CX2101A for the Treatment of COVID-19
Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID
Capturing MultiORgan Effects of COVID-19
Novel Experimental COVID-19 Therapies Affecting Host Response
BCG Vaccine for Health Care Workers as Defense Against COVID 19
Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19
Trial of Combination Therapy to Treat COVID-19 Infection
Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, with CoViD-19
Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)